ACEI

ACEIs/ARBs May Be Protective for COVID-19 Patients

This entry was posted in Cardiovascular Diseases Uncategorized and tagged ACEI ARB COVID-19 Mortality on by

A systematic review and meta-analysis suggests that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may be associated with protective effects for patients with COVID-19. The analysis included 52 studies that evaluated clinical outcomes among 101 949 total patients, of whom 26.0% were receiving ACEIs or ARBs. When adjusted for […]

COVID-19 Positivity Not Higher in ACEI or ARB Users

This entry was posted in Cardiovascular Diseases Uncategorized and tagged ACEI ARB COVID-19 on by

A US retrospective cohort study found no association between angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) use and COVID-19 test positivity. The study included 18 472 patients tested for COVID-19 (mean age 49 years, 40% male, and 69% white), 12.4% were taking either ACEIs or ARBs. A positive […]